Koklu, S. Et Al. 2015. Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.41, no.3 , 310-319.

Koklu, S., Gulsen, M. T., Tuna, Y., Koklu, H., Yuksel, O., Demir, M., ... Guner, R.(2015). Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.41, no.3, 310-319.

Koklu, S. Et Al. "Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.41, no.3, 310-319, 2015

Koklu, S. Et Al. "Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.41, no.3, pp.310-319, 2015

Koklu, S. Et Al. (2015) . "Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.41, no.3, pp.310-319.

@article{article, author={S. Koklu Et Al. }, title={Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B}, journal={ALIMENTARY PHARMACOLOGY & THERAPEUTICS}, year=2015, pages={310-319} }